Alignment Healthcare (NASDAQ:ALHC) Posts Earnings Results, Beats Estimates By $0.02 EPS

Alignment Healthcare (NASDAQ:ALHC) released its earnings results on Thursday. The company reported ($0.16) EPS for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.02, Zacks reports. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%.

Alignment Healthcare Stock Performance

ALHC traded up $0.31 on Thursday, reaching $13.47. The company had a trading volume of 1,237,491 shares, compared to its average volume of 1,867,617. Alignment Healthcare has a 1 year low of $4.46 and a 1 year high of $15.82. The stock has a market capitalization of $2.58 billion, a PE ratio of -17.49 and a beta of 1.50. The stock has a 50-day moving average price of $13.34 and a 200-day moving average price of $11.88. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82.

Insider Activity at Alignment Healthcare

In other news, COO Sebastian Burzacchi sold 8,550 shares of the business’s stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $11.26, for a total value of $96,273.00. Following the completion of the sale, the chief operating officer now owns 217,395 shares of the company’s stock, valued at approximately $2,447,867.70. The trade was a 3.78 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Hakan Kardes sold 10,500 shares of the business’s stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $14.99, for a total transaction of $157,395.00. Following the sale, the insider now directly owns 309,944 shares of the company’s stock, valued at approximately $4,646,060.56. This represents a 3.28 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 441,002 shares of company stock worth $5,772,726 over the last 90 days. Company insiders own 6.60% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on ALHC shares. Stephens reissued an “overweight” rating and issued a $17.00 target price on shares of Alignment Healthcare in a report on Monday. Stifel Nicolaus lifted their price objective on Alignment Healthcare from $14.00 to $16.00 and gave the stock a “buy” rating in a report on Tuesday, January 14th. UBS Group lifted their target price on Alignment Healthcare from $9.00 to $12.00 and gave the company a “neutral” rating in a research report on Wednesday, October 30th. Finally, Barclays boosted their price objective on Alignment Healthcare from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 30th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $11.88.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.